Study Finds DMT Induces Trip Similar to Near Death Experience
There have long been anecdotal similarities between Near-Death Experiences (NDEs) and psychedelic trips induced by Dimethyltryptamine, or DMT. Within these experiences there are uncanny parallels, including out-of-body-experiences, traveling down a tunnel toward a white light, meetings with extra-dimensional or divine entities, and a feeling of being at peace. Then upon return to reality, there is often an overwhelming sense of gratitude for simply being alive that lingers indefinitely.
And now a study conducted at London’s Imperial College has been the first to scientifically compare these resemblances.
The study, which was headed by the young impresario of the university’s Psychedelic Research Group, Robin Carhart-Harris, administered DMT intravenously to 13 participants who had prior experience using psychedelics ranging from DMT, to psilocybin and LSD.
Two traits the study tested were the commonly reported ego-dissolution and the mystical or religious experience. To qualify these highly subjective experiences, they used two standardized tests created by colleagues: The Mystical Experience Questionnaire and the Validation of the Ego-Dissolution Inventory (EDI).
In their experiment, Carhart-Harris and colleagues administered a range of doses to participants in a single-blind study over two sessions, of which one session only a placebo was given.
Their results showed that every participant rated their DMT experience above the conventional cutoff for an NDE, essentially ranking the DMT trip higher than the minimum level one might consider an experience to be an NDE. They concluded, “results show that near-death experience phenomena were significantly enhanced following DMT administration.”
Watch this episode of Psychedelica in which we explore the scientific studies being conducted with DMT: The Spirit Molecule:
The theme of death and rebirth is also rife within the ayahuasca experience. The names of the plants used to create the ayahuasca brew contain references to death, while the word ayahuasca translates to ‘vine of the dead’ or ‘vine of the soul.
Not so surprisingly, when Raymond Moody coined the phrase “Near-Death Experience” in 1975, he actually noted the comparisons between NDEs and DMT trips. Today, after four decades of clinical research and a relaxation of certain taboos, the study of DMT has revealed it is an endogenous chemical, produced in varying quantities in the lungs and in cerebral spinal fluid.
When the DMT molecule was studied in a lab by Dr. Rick Strassman – head of the first clinical study to administer DMT in the United States – he found that it minimized neuronal damage from hypoxia, a lack of oxygen in the brain. This discovery led Strassman to entertain the idea that maybe the body releases DMT in emergency situations when the brain’s oxygen supply is dwindling, producing the psychedelic NDE. Could this explain the similarities?
Watch Dr. Raymond Moody discuss Near Death Experiences on this episode of Beyond Belief:
Strongest Psychedelic Known to Man Now Being Used in Clinical Trials
The world’s first regulated clinical trial of DMT clears the way for Earth’s most powerful psychoactive drug to join the psychedelic therapy revolution.
DMT, or N, N-Dimethyltryptamine, is a highly potent hallucinogen that naturally occurs in many plant species, including in one of the plant ingredients of ayahuasca. It can also be synthetically produced in a laboratory.
DMT is known for inducing intense metaphysical trips, which are reportedly similar to near-death experiences. Having been used underground in the west for decades, it is now attracting the interest of pharmaceutical companies and scientists looking to investigate its potential mental health benefits.
Jay Waxenberg is the director of the DMTx program at the Center for Medicinal Mindfulness. Based in Boulder, CO, it was one of the first centers to offer legal psychedelic therapy in the U.S.
“DMT is actually the most powerful psychedelic on Earth that we’re aware of, and what makes it special and different from other psychedelics is that it’s endogenous, which means it’s produced within our own bodies. It’s also produced in nearly every ecosystem on Earth — it’s everywhere, it’s all around us – which is also kind of leading to what is really unique about it, the extent of a DMT experience, it’s at most 20 minutes,” Waxenberg said.
While there is a wide range of phenomena experienced during a DMT trip, there are some fascinating common hallmarks.
“This alternate reality experience, or this experience that people will call ‘realer than real.’ It’s a reality similar to our own, but completely different,” Waxenberg said. “Some of the elements within that would be the entity encounters, which is very common for people; intense geometric, hyperbolic shapes; and out-of-body, traveling to the center of the universe; ego-dissolution, ego death; these are really common experiences under it.”
While advocates have been reporting profound healing benefits for decades, there have not been any clinical studies on DMT due to its status as a Schedule 1 controlled substance, until now.